biotech in l a

biotech in l a

A Culver City-based biotech company is testing COVID vaccinations it hopes will be effective against more contagious variants that have emerged from South Africa, California, Brazil and the U.K.

Read more Show less

On this week's episode of LA Venture, hear from Sean Harper, founding managing director of Westlake Village BioPartners, which has two new funds totaling $500 million that's catalyzing the L.A. biotech ecosystem. Harper is the former head of research and development at biopharmaceutical company Amgen. He shares his focus on therapeutics to improve human lives and starting Westlake with Beth Seidenberg.

Read more Show less

Westlake Village BioPartners, the two-year-old Los Angeles venture capital firm investing in life science and therapeutic companies, has raised two new funds totaling $500 million. The announcement Tuesday brings the firm to $820 million in capital to date.

The first fund, called Opportunity 1, carves out $70 million for Westlake to invest Series B or later-stage rounds for companies they incubated or invested in previously.

Meanwhile, Westlake Village BioPartners 2 Fund is a $430 million stash for incubating and investing in about 12 Series A startups. The VC firm will also use that fund for other Series B or late-round investments.

Read more Show less
Trending